Atypical Papanicolaou Smear in Pregnancy

Overview

Journal Clin Med Res

Specialty General Medicine

Date 2005 Jun 18

PMID 15962016

Authors

Thomas P Connolly

A C Evans

Affiliations

Soon will be listed here.

Abstract

Atypical glandular cells (AGC) in Papanicolaou (Pap) smears can be associated with premalignant and malignant cervical and endometrial lesions. AGC is difficult to diagnose in pregnancy due to confusion with normal cellular changes that accompany graviditas. While guidelines have been established for management of AGC cases in the non-pregnant patient, special considerations are required when this is discovered during a pregnancy. A routine Pap smear performed on a 29-year-old woman being seen for a history of infertility yielded AGC and a high-grade squamous intraepithelial lesion. The patient achieved pregnancy 1 month later. Satisfactory colposcopic exam was performed with cytobrush sampling of the endocervical canal, in addition to 2 exocervical biopsies at 11 weeks gestation. Positive diagnosis of endocervical adenocarcinoma in situ resulted in a risk-informed decision to proceed with a cold knife conization of the cervix. Final pathology showed complete resection of the lesion with negative margins and an additional area of squamous dysplasia (cervical intraepithelial neoplasia, grade II to III). Appropriate follow-up was recommended. AGC found upon Pap smear during a pregnancy can be associated with significant pathology for which an aggressive management approach is warranted.

References

Azodi M, Chambers S, Rutherford T, Kohorn E, Schwartz P, Chambers J . Adenocarcinoma in situ of the cervix: management and outcome. Gynecol Oncol. 1999; 73(3):348-53. DOI: 10.1006/gyno.1999.5395. View

Raab S, Bishop N, Zaleski M . Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance. Gynecol Oncol. 1999; 74(3):460-4. DOI: 10.1006/gyno.1999.5512. View

Jones 3rd H . Clinical treatment of women with atypical squamous cells of undetermined significance or atypical glandular cells of undetermined significance cervical cytology. Clin Obstet Gynecol. 2000; 43(2):381-93. DOI: 10.1097/00003081-200006000-00017. View

Raab S . Can glandular lesions be diagnosed in pap smear cytology?. Diagn Cytopathol. 2000; 23(2):127-33. DOI: 10.1002/1097-0339(200008)23:2<127::aid-dc13>3.0.co;2-i. View

Soofer S, Sidawy M . Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer. 2000; 90(4):207-14. View

Shin C, Schorge J, Lee K, Sheets E . Conservative management of adenocarcinoma in situ of the cervix. Gynecol Oncol. 2000; 79(1):6-10. DOI: 10.1006/gyno.2000.5962. View

Ostor A, Duncan A, Quinn M, Rome R . Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol. 2000; 79(2):207-10. DOI: 10.1006/gyno.2000.5957. View

Valdini A, Vaccaro C, Pechinsky G, Abernathy V . Incidence and evaluation of an AGUS Papanicolaou smear in primary care. J Am Board Fam Pract. 2001; 14(3):172-7. View

Chhieng D, Elgert P, Cangiarella J, Cohen J . Significance of AGUS Pap smears in pregnant and postpartum women. Acta Cytol. 2001; 45(3):294-9. DOI: 10.1159/000327621. View

10.

Kaferle J, Malouin J . Evaluation and management of the AGUS Papanicolaou smear. Am Fam Physician. 2001; 63(11):2239-44. View

11.

Massad L, Collins Y, Meyer P . Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001; 82(3):516-22. DOI: 10.1006/gyno.2001.6323. View

12.

Reuss E, Price J, Koonings P . Atypical glandular cells of undetermined significance. Subtyping as a predictor of outcome. J Reprod Med. 2001; 46(8):701-5. View

13.

Cox J . Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testing. Best Pract Res Clin Obstet Gynaecol. 2001; 15(5):715-41. DOI: 10.1053/beog.2001.0216. View

14.

Nasuti J, Fleisher S, Gupta P . Atypical glandular cells of undetermined significance (AGUS): clinical considerations and cytohistologic correlation. Diagn Cytopathol. 2002; 26(3):186-90. DOI: 10.1002/dc.10070. View

15.

Solomon D, Davey D, Kurman R, Moriarty A, OConnor D, Prey M . The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16):2114-9. DOI: 10.1001/jama.287.16.2114. View

16.

Wright Jr T, Cox J, Massad L, Twiggs L, Wilkinson E . 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002; 287(16):2120-9. DOI: 10.1001/jama.287.16.2120. View

17.

Meath A, Carley M, Wilson T . Atypical glandular cells of undetermined significance. Review of final histologic diagnoses. J Reprod Med. 2002; 47(4):249-52. View

18.

Hammoud M, Haefner H, Michael C, Ansbacher R . Atypical glandular cells of undetermined significance. Histologic findings and proposed management. J Reprod Med. 2002; 47(4):266-70. View

19.

Soegaard Andersen E, Nielsen K . Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment. Gynecol Oncol. 2002; 86(3):365-9. DOI: 10.1006/gyno.2002.6758. View

20.

Lea J, Shin C, Sheets E, Coleman R, Gehrig P, Duska L . Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ. Gynecol Oncol. 2002; 87(1):129-32. DOI: 10.1006/gyno.2002.6791. View